USD 1.43
(-0.35%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.34 Million USD | -20.27% |
2022 | 2.94 Million USD | 601.91% |
2021 | 419 Thousand USD | -99.76% |
2020 | 172.22 Million USD | 8.93% |
2019 | 158.1 Million USD | 0.97% |
2018 | 156.58 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 2.27 Million USD | -3.2% |
2024 Q2 | 1.55 Million USD | -31.41% |
2023 Q3 | 450 Thousand USD | 23.63% |
2023 FY | 2.34 Million USD | -20.27% |
2023 Q2 | 364 Thousand USD | 62.5% |
2023 Q1 | 224 Thousand USD | -92.38% |
2023 Q4 | 2.34 Million USD | 421.11% |
2022 Q3 | 4.72 Million USD | -14.72% |
2022 FY | 2.94 Million USD | 601.91% |
2022 Q4 | 2.94 Million USD | -37.77% |
2022 Q2 | 5.54 Million USD | -12.68% |
2022 Q1 | 6.34 Million USD | 1414.8% |
2021 Q4 | 419 Thousand USD | 72.43% |
2021 FY | 419 Thousand USD | -99.76% |
2021 Q1 | 213.95 Million USD | 24.23% |
2021 Q2 | 181.99 Million USD | -14.94% |
2021 Q3 | 243 Thousand USD | -99.87% |
2020 FY | 172.22 Million USD | 8.93% |
2020 Q4 | 172.22 Million USD | -3.87% |
2020 Q3 | 179.16 Million USD | 0.0% |
2020 Q1 | - USD | -100.0% |
2019 FY | 158.1 Million USD | 0.97% |
2019 Q4 | 158.1 Million USD | 0.0% |
2018 FY | 156.58 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Inovalon Holdings, Inc. | 897.3 Million USD | 99.739% |
GE HealthCare Technologies Inc. | 9.86 Billion USD | 99.976% |
Progyny, Inc. | 19.39 Million USD | 87.906% |
Aclarion, Inc. | 1.12 Million USD | -108.31% |
CareMax, Inc. | 491.93 Million USD | 99.523% |
Simulations Plus, Inc. | 475 Thousand USD | -393.684% |
CareCloud, Inc. | 14.73 Million USD | 84.083% |
Forian Inc. | 23 Million USD | 89.805% |
Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
Minerva Surgical, Inc. | 39.69 Million USD | 94.092% |
Omnicell, Inc. | 614.09 Million USD | 99.618% |
Definitive Healthcare Corp. | 267.92 Million USD | 99.125% |
Zhongchao Inc. | 808.15 Thousand USD | -190.167% |
Accolade, Inc. | 241.64 Million USD | 99.03% |
Streamline Health Solutions, Inc. | 10.56 Million USD | 77.806% |
Ontrak, Inc. | 1.68 Million USD | -38.84% |
SOPHiA GENETICS SA | 18.6 Million USD | 87.393% |
R1 RCM Inc. | 1.74 Billion USD | 99.865% |
Spok Holdings, Inc. | 11.08 Million USD | 78.847% |
Privia Health Group, Inc. | 8.28 Million USD | 71.709% |
EUDA Health Holdings Limited | 3.37 Million USD | 30.509% |
HeartBeam, Inc. | - USD | -Infinity% |
GeneDx Holdings Corp. | 119.77 Million USD | 98.042% |
TruBridge, Inc. | 203.28 Million USD | 98.846% |
Nutex Health, Inc. | 275.75 Million USD | 99.15% |
Renalytix Plc | 8.53 Million USD | 72.525% |
Sharecare, Inc. | 2.34 Million USD | 0.0% |
Health Catalyst, Inc. | 249.06 Million USD | 99.058% |
10x Genomics, Inc. | 95.37 Million USD | 97.541% |
GoodRx Holdings, Inc. | 711.07 Million USD | 99.67% |
SCWorx Corp. | 90.35 Thousand USD | -2495.204% |
Schrödinger, Inc. | 127.88 Million USD | 98.166% |
HealthEquity, Inc. | 933.14 Million USD | 99.749% |
HealthStream, Inc. | 23.22 Million USD | 89.901% |
MSP Recovery, Inc. | 679.32 Million USD | 99.655% |
Augmedix, Inc. | 25.84 Million USD | 90.927% |
BrightSpring Health Services, Inc. Common Stock | 3.67 Billion USD | 99.936% |
Ontrak, Inc. | 1.68 Million USD | -38.84% |
SHL Telemedicine Ltd. | 19.85 Million USD | 88.187% |
CareCloud, Inc. | 14.73 Million USD | 84.083% |
Premier, Inc. | 126 Million USD | 98.139% |
Certara, Inc. | 298.19 Million USD | 99.214% |
GeneDx Holdings Corp. | 119.77 Million USD | 98.042% |
OneMedNet Corporation | 5.1 Million USD | 54.031% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 3.67 Billion USD | 99.936% |
EUDA Health Holdings Limited | 3.37 Million USD | 30.509% |
HeartBeam, Inc. | - USD | -Infinity% |
CareCloud, Inc. | 14.73 Million USD | 84.083% |
Mangoceuticals, Inc. | 128.67 Thousand USD | -1722.378% |
CareMax, Inc. | 491.93 Million USD | 99.523% |
Healthcare Triangle, Inc. | 4.31 Million USD | 45.68% |
National Research Corporation | 38.95 Million USD | 93.98% |
Aclarion, Inc. | 1.12 Million USD | -108.31% |
OptimizeRx Corporation | 36.82 Million USD | 93.632% |